| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.612 | 0.019 | 0.612 | Antiobesity | 0.504 0.036 CID_154700114 | ||
| 0.517 | 0.022 | 0.517 | Calcium channel L-type activator | 0.235 0.222 CID_154699471 0.506 0.025 CID_154700114 | ||
| 0.414 | 0.002 | 0.414 | Beta 2 adrenoreceptor antagonist | 0.064 0.02 CID_154699471 0.147 0.005 CID_154700114 | ||
| 0.379 | 0.003 | 0.379 | Adrenaline agonist | 0.089 0.047 CID_154699471 0.202 0.007 CID_154700114 | ||
| 0.374 | 0.002 | 0.374 | Beta 1 adrenoreceptor antagonist | 0.081 0.017 CID_154699471 0.159 0.004 CID_154700114 | ||
| 0.363 | 0.006 | 0.475 | Bronchodilator | 0.475 0.005 CID_154700114 | CID_154700114 | |
| 0.406 | 0.055 | 0.451 | MAP kinase kinase 6 inhibitor | 0.451 0.034 CID_154699471 0.388 0.066 CID_154700114 | CID_154699471 | |
| 0.341 | 0.011 | 0.341 | Antiadrenergic | 0.22 0.021 CID_154700114 | ||
| 0.341 | 0.011 | 0.341 | Adrenaline antagonist | 0.219 0.02 CID_154700114 | ||
| 0.383 | 0.067 | 0.688 | Toll-Like receptor 7 agonist | 0.688 0.009 CID_154700114 | CID_154700114 | |
| 0.375 | 0.07 | 0.681 | Toll-Like receptor agonist | 0.681 0.01 CID_154700114 | CID_154700114 | |
| 0.3 | 0.002 | 0.3 | Beta 3 adrenoreceptor agonist | 0.03 0.004 CID_154700114 | ||
| 0.368 | 0.11 | 0.414 | Cyclophilin D inhibitor | 0.414 0.084 CID_154700114 | CID_154700114 | |
| 0.245 | 0.003 | 0.245 | Beta adrenoreceptor antagonist | 0.07 0.038 CID_154699471 0.132 0.008 CID_154700114 | ||
| 0.231 | 0.004 | 0.231 | Beta 3 adrenoreceptor antagonist | 0.069 0.035 CID_154699471 0.145 0.006 CID_154700114 | ||
| 0.266 | 0.072 | 0.266 | Cardiotonic | 0.206 0.113 CID_154699471 0.224 0.1 CID_154700114 | ||
| 0.196 | 0.012 | 0.196 | Pregnane X receptor agonist | 0.176 0.021 CID_154699471 0.149 0.054 CID_154700114 | ||
| 0.176 | 0.003 | 0.176 | Beta adrenoreceptor agonist | 0.043 0.042 CID_154699471 0.065 0.006 CID_154700114 | ||
| 0.229 | 0.058 | 0.229 | MAP kinase kinase 3 inhibitor | 0.222 0.071 CID_154699471 0.183 0.179 CID_154700114 | ||
| 0.189 | 0.085 | 0.189 | Insulin sensitizer | |||
| 0.138 | 0.036 | 0.142 | Nav1.5 sodium channel blocker | 0.142 0.032 CID_154699471 | CID_154699471 | |
| 0.194 | 0.107 | 0.194 | Peptidyltransferase inhibitor | 0.176 0.135 CID_154700114 | ||
| 0.175 | 0.094 | 0.175 | Growth factor agonist | |||
| 0.083 | 0.008 | 0.083 | Beta 2 adrenoreceptor agonist | 0.066 0.029 CID_154700114 | ||
| 0.133 | 0.059 | 0.144 | CC chemokine 6 receptor antagonist | 0.144 0.032 CID_154699471 0.121 0.111 CID_154700114 | CID_154699471 | |
| 0.094 | 0.02 | 0.094 | Potassium channel Kv1.5 blocker | 0.091 0.021 CID_154699471 | ||
| 0.117 | 0.049 | 0.351 | Carbonic anhydrase XV inhibitor | 0.351 0.005 CID_154699471 | CID_154699471 | |
| 0.091 | 0.031 | 0.091 | Vanilloid 1 antagonist | 0.058 0.057 CID_154700114 | ||
| 0.061 | 0.004 | 0.061 | Beta 1 adrenoreceptor agonist | 0.031 0.007 CID_154700114 | ||
| 0.091 | 0.04 | 0.091 | Vanilloid antagonist | |||
| 0.122 | 0.072 | 0.131 | Nav1.3 sodium channel blocker | 0.131 0.063 CID_154699471 | CID_154699471 | |
| 0.065 | 0.025 | 0.065 | Thromboxane A2 antagonist | |||
| 0.056 | 0.024 | 0.056 | Alpha 1b adrenoreceptor agonist | 0.048 0.039 CID_154700114 | ||
| 0.061 | 0.032 | 0.061 | Thromboxane antagonist | |||
| 0.116 | 0.089 | 0.223 | Sodium channel (voltage-gated) blocker | 0.223 0.022 CID_154699471 | CID_154699471 | |
| 0.086 | 0.066 | 0.086 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.025 | 0.013 | 0.025 | Alpha 1a adrenoreceptor agonist | |||
| 0.087 | 0.077 | 0.087 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.05 | 0.048 | 0.058 | Bombesin 3 receptor antagonist | 0.058 0.035 CID_154699471 | CID_154699471 | |
| 0.073 | 0.072 | 0.172 | Ca(v)2.2 blocker | 0.172 0.023 CID_154699471 | CID_154699471 | |
| 0.052 | 0.051 | 0.06 | Carbonic anhydrase stimulant | 0.06 0.04 CID_154699471 | CID_154699471 | |
| 0.008 | 0.01 | 0.017 | 2-Acylglycerol O-acyltransferase 2 inhibitor | 0.017 0.004 CID_154699471 | CID_154699471 | |
| 0.08 | 0.083 | 0.115 | Butyrylcholinesterase inhibitor | 0.115 0.05 CID_154699471 | CID_154699471 | |
| 0.019 | 0.035 | 0.026 | CC chemokine 8 receptor antagonist | 0.026 0.01 CID_154699471 0.024 0.015 CID_154700114 | CID_154699471 | |
| 0.098 | 0.116 | 0.219 | Sodium channel blocker | 0.219 0.026 CID_154699471 | CID_154699471 | |
| 0.033 | 0.052 | 0.057 | Phenylethanolamine N methyltransferase inhibitor | 0.057 0.009 CID_154699471 | CID_154699471 | |
| 0.054 | 0.079 | 0.09 | Transcription factor RelA inhibitor | 0.09 0.01 CID_154699471 | CID_154699471 | |
| 0.021 | 0.046 | 0.03 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.03 0.029 CID_154699471 | CID_154699471 | |
| 0.081 | 0.106 | 0.157 | Adenylate cyclase inhibitor | 0.157 0.04 CID_154699471 | CID_154699471 | |
| 0.021 | 0.05 | 0.1 | 5 Hydroxytryptamine 6 agonist | 0.1 0.003 CID_154699471 | CID_154699471 | |
| 0.055 | 0.088 | 0.123 | CC chemokine receptor antagonist | 0.081 0.05 CID_154699471 0.123 0.025 CID_154700114 | CID_154700114 | |
| 0.023 | 0.058 | 0.031 | LIM domain kinase 2 inhibitor | 0.031 0.021 CID_154699471 | CID_154699471 | |
| 0.044 | 0.081 | 0.056 | Sphingosine 1-phosphate receptor 1 antagonist | 0.056 0.038 CID_154699471 | CID_154699471 | |
| 0.049 | 0.096 | 0.086 | Trypsin inhibitor | 0.086 0.024 CID_154699471 | CID_154699471 | |
| 0.045 | 0.092 | 0.105 | Nav1.7 sodium channel blocker | 0.105 0.021 CID_154699471 | CID_154699471 | |
| 0.065 | 0.114 | 0.145 | Chemokine receptor antagonist | 0.107 0.057 CID_154699471 0.145 0.034 CID_154700114 | CID_154700114 | |
| 0.018 | 0.068 | 0.03 | Myristoyl transferase inhibitor | 0.03 0.014 CID_154699471 | CID_154699471 | |
| 0.044 | 0.096 | 0.146 | Carbonic anhydrase VA inhibitor | 0.146 0.012 CID_154699471 0.063 0.055 CID_154700114 | CID_154699471 | |
| 0.099 | 0.157 | 0.13 | Insulin secretagoues | 0.13 0.097 CID_154700114 | CID_154700114 | |
| 0.017 | 0.077 | 0.09 | Carbonic anhydrase IV inhibitor | 0.09 0.009 CID_154699471 | CID_154699471 | |
| 0.018 | 0.082 | 0.046 | Carbonic anhydrase I stimulant | 0.046 0.019 CID_154699471 | CID_154699471 | |
| 0.036 | 0.102 | 0.153 | Carbonic anhydrase V inhibitor | 0.153 0.014 CID_154699471 | CID_154699471 | |
| 0.053 | 0.12 | 0.205 | Carbonic anhydrase VI inhibitor | 0.205 0.013 CID_154699471 0.075 0.064 CID_154700114 | CID_154699471 | |
| 0.046 | 0.116 | 0.057 | Bcl-xL inhibitor | 0.057 0.051 CID_154699471 | CID_154699471 | |
| 0.031 | 0.102 | 0.154 | 5 Hydroxytryptamine 6 antagonist | 0.154 0.005 CID_154699471 | CID_154699471 | |
| 0.015 | 0.088 | 0.033 | AMPA receptor agonist | 0.033 0.029 CID_154699471 | CID_154699471 | |
| 0.021 | 0.098 | 0.035 | Vanilloid 4 antagonist | 0.035 0.018 CID_154699471 | CID_154699471 | |
| 0.018 | 0.096 | 0.071 | Dihydropteroate synthase inhibitor | 0.071 0.008 CID_154699471 | CID_154699471 | |
| 0.033 | 0.112 | 0.06 | Carbonic anhydrase II stimulant | 0.06 0.023 CID_154699471 | CID_154699471 | |
| 0.019 | 0.102 | 0.13 | Carbonic anhydrase VB inhibitor | 0.13 0.011 CID_154699471 | CID_154699471 | |
| 0.029 | 0.119 | 0.055 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.055 0.036 CID_154699471 | CID_154699471 | |
| 0.063 | 0.157 | 0.122 | Electrolyte absorption antagonist | 0.122 0.034 CID_154699471 | CID_154699471 | |
| 0.014 | 0.112 | 0.024 | Integrin alpha2beta1 antagonist | 0.024 0.023 CID_154699471 | CID_154699471 | |
| 0.005 | 0.106 | 0.039 | Growth hormone secretagogue receptor agonist | 0.039 0.022 CID_154699471 | CID_154699471 | |
| 0.115 | 0.219 | 0.222 | Vasodilator | 0.222 0.088 CID_154700114 | CID_154700114 | |
| 0.057 | 0.188 | 0.097 | AMP-activated protein kinase stimulant | 0.097 0.075 CID_154699471 | CID_154699471 | |
| 0.062 | 0.194 | 0.136 | Alkaline phosphatase inhibitor | 0.136 0.07 CID_154699471 | CID_154699471 | |
| 0.053 | 0.196 | 0.103 | Carbonic anhydrase III inhibitor | 0.103 0.059 CID_154699471 | CID_154699471 | |
| 0.011 | 0.156 | 0.085 | Carbonic anhydrase I inhibitor | 0.085 0.023 CID_154699471 | CID_154699471 | |
| 0.106 | 0.262 | 0.148 | Catenin beta inhibitor | 0.148 0.109 CID_154699471 | CID_154699471 | |
| 0.103 | 0.263 | 0.144 | Death-associated protein kinase 2 inhibitor | 0.144 0.12 CID_154699471 | CID_154699471 | |
| 0.03 | 0.189 | 0.115 | CYP2A6 inhibitor | 0.115 0.029 CID_154699471 | CID_154699471 | |
| 0.009 | 0.177 | 0.074 | Carbonic anhydrase II inhibitor | 0.074 0.028 CID_154699471 | CID_154699471 | |
| 0.033 | 0.202 | 0.063 | Bcl2 antagonist | 0.063 0.051 CID_154699471 | CID_154699471 | |
| 0.091 | 0.262 | 0.176 | Focal adhesion kinase 2 inhibitor | 0.176 0.092 CID_154699471 | CID_154699471 | |
| 0.048 | 0.225 | 0.122 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.122 0.099 CID_154699471 | CID_154699471 | |
| 0.024 | 0.222 | 0.121 | Carbonic anhydrase XIII inhibitor | 0.121 0.029 CID_154699471 | CID_154699471 | |
| 0.009 | 0.209 | 0.076 | Carbonic anhydrase inhibitor | 0.076 0.037 CID_154699471 | CID_154699471 | |
| 0.104 | 0.331 | 0.26 | Transcription factor STAT inhibitor | 0.26 0.08 CID_154699471 | CID_154699471 | |
| 0.05 | 0.278 | 0.107 | Calcium channel N-type blocker | 0.107 0.083 CID_154699471 | CID_154699471 | |
| 0.004 | 0.235 | 0.055 | Carbonic anhydrase IX inhibitor | 0.055 0.039 CID_154699471 | CID_154699471 | |
| 0.023 | 0.257 | 0.064 | Thrombin inhibitor | 0.064 0.063 CID_154699471 | CID_154699471 | |
| 0.089 | 0.329 | 0.189 | 12-Lipoxygenase inhibitor | 0.189 0.163 CID_154699471 | CID_154699471 | |
| 0.005 | 0.248 | 0.038 | TRPM8 blocker | 0.038 0.027 CID_154699471 | CID_154699471 | |
| 0.094 | 0.338 | 0.285 | Transcription factor STAT3 inhibitor | 0.285 0.061 CID_154699471 | CID_154699471 | |
| 0.022 | 0.298 | 0.076 | Potassium channel intermediate-conductance Ca-activated blocker | 0.076 0.02 CID_154699471 | CID_154699471 | |
| 0.036 | 0.316 | 0.146 | Nav1.6 sodium channel blocker | 0.146 0.058 CID_154699471 | CID_154699471 | |
| 0.011 | 0.295 | 0.054 | 5 Hydroxytryptamine 7 antagonist | 0.054 0.051 CID_154699471 | CID_154699471 | |
| 0.07 | 0.358 | 0.268 | 5 Hydroxytryptamine 1E antagonist | 0.268 0.056 CID_154699471 | CID_154699471 | |
| 0.053 | 0.386 | 0.172 | Antipruritic | 0.172 0.072 CID_154699471 | CID_154699471 | |
| 0.005 | 0.342 | 0.047 | Kinesin-like protein 1 inhibitor | 0.047 0.017 CID_154699471 | CID_154699471 | |
| 0.005 | 0.342 | 0.047 | Kinesin antagonist | 0.047 0.017 CID_154699471 | CID_154699471 | |
| 0.015 | 0.362 | 0.097 | 5 Hydroxytryptamine antagonist | 0.097 0.082 CID_154699471 | CID_154699471 | |
| 0.016 | 0.384 | 0.062 | 5 Hydroxytryptamine 1B agonist | 0.062 0.024 CID_154699471 | CID_154699471 | |
| 0.026 | 0.395 | 0.132 | Protein-tyrosine phosphatase inhibitor | 0.132 0.099 CID_154700114 | CID_154700114 | |
| 0.01 | 0.383 | 0.05 | 5 Hydroxytryptamine 2B agonist | 0.05 0.013 CID_154699471 | CID_154699471 | |
| 0.06 | 0.461 | 0.234 | 15-Lipoxygenase inhibitor | 0.234 0.178 CID_154699471 | CID_154699471 | |
| 0.036 | 0.5 | 0.202 | Tumour necrosis factor alpha release inhibitor | 0.202 0.107 CID_154700114 | CID_154700114 | |
| 0.065 | 0.544 | 0.217 | 5 Hydroxytryptamine release stimulant | 0.217 0.108 CID_154699471 | CID_154699471 | |
| 0.06 | 0.551 | 0.184 | Insulysin inhibitor | 0.184 0.183 CID_154699471 | CID_154699471 | |
| 0.005 | 0.52 | 0.107 | Phosphodiesterase 4A inhibitor | 0.107 0.014 CID_154700114 | CID_154700114 | |
| 0.072 | 0.749 | 0.167 | 5 Hydroxytryptamine 3E antagonist | 0.167 0.145 CID_154699471 | CID_154699471 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |